Search results for "TP"

showing 10 items of 4688 documents

Maternal serum ghrelin levels in early IVF pregnancies: lack of prognostic value for viable pregnancy and altered post-prandial responses

2008

Background Ghrelin is a pleiotropic hormone, involved in the control of growth and metabolism, whose circulating levels fluctuate in relation to food intake and body mass index. Ghrelin has been detected in the decidualized endometrium, as well as in human and rat placenta. Methods A total of 106 patients undergoing IVF procedures were prospectively recruited. On Days 16 and 23 after oocyte retrieval, the patients were subjected to blood sampling after overnight fasting, for determination of serum ghrelin, hCGbeta and progesterone levels. In addition, ghrelin levels were assayed in these groups, 2 h after ingestion of a fixed-calorie meal. Results The subjects were divided according to whet…

Adultmedicine.medical_specialtyFertilization in VitroBiologyEndometriumBody Mass IndexPregnancyInternal medicinemedicineHumansIngestionChorionic Gonadotropin beta Subunit HumanProspective StudiesProgesteronePregnancydigestive oral and skin physiologyRehabilitationPregnancy OutcomeObstetrics and GynecologyGestational ageFastingPostprandial PeriodPrognosismedicine.diseaseGhrelinEndocrinologymedicine.anatomical_structurePostprandialReproductive MedicineFemaleGhrelinhormones hormone substitutes and hormone antagonistsBlood samplingHormoneHuman Reproduction
researchProduct

Successful treatment of life-threatening bleeding after cesarean section with recombinant activated factor VII.

2006

Hemorrhagic shock developed in a 29-year-old nullipara without coagulopathy after emergency caesarean section. Treatment with uterotonic drugs, prostaglandins, and conservative procedures with transfusion of packed red cells and fresh-frozen plasma failed to control the diffuse vaginal and uterine bleeding. Finally an intravenous bolus injection of 90 μg/kg recombinant activated factor VII (rFVIIa, NovoSeven®, Novo Nordisk A/S, Bagsvaerd, Denmark), was given and showed success within 20 minutes after administration, without any side effects.

Adultmedicine.medical_specialtyPacked Red CellsCritical IllnessUterotonicFactor VIIa030204 cardiovascular system & hematologylaw.invention03 medical and health sciences0302 clinical medicinelawPregnancyActivated factor VIImedicineCoagulopathyHumans030212 general & internal medicinepostpartum bleedingbusiness.industryCesarean SectionPostpartum HemorrhageUterine bleedingHematologyGeneral MedicineFactor VIImedicine.diseaseRecombinant ProteinsSurgeryTreatment OutcomeAnesthesiaHemorrhagic shockRecombinant DNAFemalebusinessClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
researchProduct

Feasibility of a modified outpatient regimen of intravenous/intraperitoneal chemotherapy in optimally debulked stage III ovarian cancer patients: a G…

2011

Objectives: The objective of the study was to assess the feasibility, toxicity, and reasons for early discontinuation of a modified outpatient intraperitoneal/intravenous (IP/IV) chemotherapy regimen for the treatment of patients with optimally debulked stage III ovarian cancer. Methods: Between February 2006 and November 2008, 51 consecutive patients from Institutions of the Spanish Ovarian Cancer Group (GEICO) were treated with a modified outpatient IP chemotherapy regimen. Patients received IV paclitaxel 175 mg/m2 over 3 hours on day 1, followed by IP cisplatin 100 mg/m2 (or 75 mg/m2 according to the principal investigator9s criteria) on day 2. On day 8, patients received IP paclitaxel 6…

Adultmedicine.medical_specialtyPaclitaxelmedicine.medical_treatmentNeutropeniaCarcinoma Ovarian EpithelialDrug Administration ScheduleAntineoplastic Combined Chemotherapy ProtocolsOutpatientsMedicineHumansInfusions ParenteralNeoplasms Glandular and EpithelialProspective StudiesProspective cohort studyInfusions IntravenousAgedNeoplasm StagingStage III Ovarian CancerOvarian NeoplasmsChemotherapybusiness.industryObstetrics and GynecologyMiddle Agedmedicine.diseaseChemotherapy regimenSurgeryClinical trialRegimenTreatment OutcomeOncologySpainFeasibility StudiesFemaleCisplatinbusinessOvarian cancerInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society
researchProduct

Drop-out and treatment outcome of outpatient cognitive-behavioral therapy for anorexia nervosa and bulimia nervosa.

2013

In the present study, drop-out-analyses were carried out for a manual-based cognitive–behavioral therapy for 104 females with anorexia nervosa (AN) and bulimia nervosa (BN), in the service setting of a university outpatient clinic (naturalistic setting). A total of 22.9% of patients with AN terminated therapy prematurely (drop-outs), compared to 40.6% of patients with BN. Group differences between drop-outs and completers show that the group of drop-outs with BN had higher values in the depression score at the start of therapy and was almost two times more likely to have a comorbid disorder (odds ratio 1.69), whereas drop-outs with AN had higher values in the outcome-scale drive for thinnes…

Adultmedicine.medical_specialtyPediatricsAnorexia NervosaPatient Dropoutslcsh:RC435-571medicine.medical_treatmentTreatment outcomePersonality DisordersDrop outlcsh:Psychiatrymental disordersparasitic diseasesOutpatientsmedicineOutpatient clinicHumansPsychiatryBulimia NervosaCognitive Behavioral TherapyBulimia nervosaOdds ratiomedicine.diseaseCognitive behavioral therapyPsychiatry and Mental healthClinical PsychologyTreatment OutcomeAnorexia nervosa (differential diagnoses)FemalePsychologyBody mass indexhuman activitiesComprehensive psychiatry
researchProduct

Changes in Periodontal Parameters and C-Reactive Protein After Pregnancy.

2016

This study assesses hormonal, inflammatory, and periodontal changes in pregnant women and postpartum in the absence of periodontal treatment, and seeks to determine any correlations among these parameters.A longitudinal, observational study of 117 pregnant women (aged 23 to 42 years) was undertaken in a private gynecologic center between weeks 32 and 35 of pregnancy and 6 to 8 weeks after delivery. Levels of progesterone and C-reactive protein (CRP) in plasma were determined, as well as periodontal indices, including: 1) plaque index (PI); 2) bleeding on probing (BOP); 3) probing depth (PD); and 4) clinical attachment level (CAL).Postpartum progesterone and CRP declined sharply from 90.85 ±…

Adultmedicine.medical_specialtyPeriodontal treatmentPlaque indexBleeding on probing03 medical and health sciences0302 clinical medicinePregnancyPeriodontal Attachment LossmedicineHumansPeriodontal IndicesPeriodontal DiseasesGynecologyPeriodontitisPregnancy030219 obstetrics & reproductive medicinebiologybusiness.industryC-reactive proteinDental Plaque IndexPostpartum Period030206 dentistrymedicine.diseaseC-Reactive Proteinbiology.proteinPeriodonticsFemalemedicine.symptomPeriodontal IndexbusinessHormoneJournal of periodontology
researchProduct

The effect of prenatal lifestyle intervention on weight retention 12 months postpartum: results of the Norwegian Fit for Delivery randomised controll…

2015

Objective To examine the effect of a prenatal lifestyle intervention on postpartum weight retention (PPWR). Design Randomised controlled trial. Setting Healthcare clinics in southern Norway. Population Healthy, nulliparous women with body mass index ≥19 kg/m2 , age ≥18 years, and singleton pregnancy of ≤20 gestational weeks. Methods Women were randomised to intervention (dietary counselling twice by phone and access to twice-weekly exercise groups during pregnancy) or control group (standard prenatal care). Intervention compliance was defined post-factum as attending dietary counselling and ≥14 exercise classes. Main outcome measures PPWR (weight measured postpartum minus self-reported pre-…

Adultmedicine.medical_specialtyTime FactorsPopulationPrenatal careWeight Gainlaw.inventionBody Mass Index03 medical and health sciences0302 clinical medicineRandomized controlled triallawPregnancyRisk FactorsmedicineHumans030212 general & internal medicineObesityeducationExerciseLife StylePregnancyeducation.field_of_study030219 obstetrics & reproductive medicinebusiness.industryObstetricsNorwayPostpartum PeriodPregnancy OutcomeObstetrics and GynecologyPrenatal CareOdds ratioVitaminsmedicine.diseasePregnancy ComplicationsPhysical therapyFemalemedicine.symptombusinessBody mass indexWeight gainPostpartum periodBJOG : an international journal of obstetrics and gynaecology
researchProduct

How does a lifestyle intervention during pregnancy influence perceived barriers to leisure-time physical activity? The Norwegian fit for delivery stu…

2018

Abstract Background To develop effective health promotional and preventive prenatal programs, it is important to understand perceived barriers to leisure-time physical activity during pregnancy, including exercise and sport participation. The aims of the present study was 1) to assess the effect of prenatal lifestyle intervention on the perceived barrier to leisure-time physical activity during pregnancy and the first year after delivery and 2) identify the most important perceived barriers to leisure-time physical activity at multiple time points during and after pregnancy. Methods This secondary analysis was part of the Norwegian Fit for Delivery study, a combined lifestyle intervention e…

Adultmedicine.medical_specialtyTime FactorsReproductive medicineDirective CounselingHealth PromotionPrenatal carelcsh:Gynecology and obstetricslaw.inventionYoung Adult03 medical and health sciencesLeisure Activities0302 clinical medicineRandomized controlled triallawPregnancyIntervention (counseling)medicineHumans030212 general & internal medicineExerciseLife StyleFatiguelcsh:RG1-991Self-efficacyMotivationPregnancy030219 obstetrics & reproductive medicineNorwaybusiness.industryPhysical activitySupervised exerciseObstetrics and GynecologyPrenatal CareFearmedicine.diseaseSelf EfficacyDietPhysical therapyFemalebusinessBody mass indexPostpartum periodBarriersRCTResearch Article
researchProduct

Breastfeeding initiation and duration in France: The importance of intergenerational and previous maternal breastfeeding experiences — results from t…

2019

International audience; OBJECTIVE: To assess the role of the mother's mother and mothers' previous personal experiences with breastfeeding and childcare in breastfeeding practices. DESIGN AND SETTING: The analysis included 13,774 mother-infant dyads from the French national birth cohort ELFE. Feeding practices were assessed by face-to-face interview in maternity wards in 2011, by phone interviews at months 2 and 12 post-partum and by Internet/paper questionnaires monthly from months 3-10. Sociodemographic, maternal and newborn-related factors were collected in the maternity unit and by postnatal phone interview at month 2. Multivariable logistic and linear regression was used to assess the …

Adultmedicine.medical_specialtyTime Factorslongitudinalbreastfeeding[SDV]Life Sciences [q-bio]BreastfeedingPsychological interventionMothersContext (language use)[SHS.DEMO]Humanities and Social Sciences/DemographyChoice BehaviorCohort Studies03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesMaternity and MidwiferymedicineHumansDuration (project management)ComputingMilieux_MISCELLANEOUSIntergenerational transmission030219 obstetrics & reproductive medicine030504 nursing[SHS.DEMO] Humanities and Social Sciences/Demographybusiness.industryPostpartum PeriodtransmissionObstetrics and Gynecologybirth cohort3. Good healthPhone interviewGrandparents[SDV] Life Sciences [q-bio]Breast FeedingLogistic ModelsSocioeconomic FactorsFamily medicineIntergenerational RelationsintergenerationalFemalePersonal experienceFrance0305 other medical sciencebusinessBirth cohortAttitude to Health
researchProduct

Missed opportunities for tuberculosis investigation in a municipal hospital in Ghana: evidence from patient exit interviews

2020

Abstract Background We assessed coverage of symptom screening and sputum testing for tuberculosis (TB) in hospital outpatient clinics in Ghana. Methods In a cross-sectional study, we enrolled adults (≥18 years) exiting the clinics reporting ≥1 TB symptom (cough, fever, night sweats or weight loss). Participants reporting a cough ≥2 weeks or a cough of any duration plus ≥2 other TB symptoms (per national criteria) and those self-reporting HIV-positive status were asked to give sputum for testing with Xpert MTB/RIF. Results We enrolled 581 participants (median age 33 years [IQR: 24–48], 510/581 [87.8%] female). The most common symptoms were fever (348, 59.9%), chest pain (282, 48.5%) and coug…

Adultmedicine.medical_specialtyTuberculosisHIV InfectionsChest painGhanaSensitivity and SpecificitySputum testingWeight lossInternal medicinemedicineHumansTuberculosisOutpatient clinicHospitals Municipalbusiness.industrySputumPublic Health Environmental and Occupational HealthMycobacterium tuberculosisGeneral MedicineOdds ratiomedicine.diseaseConfidence intervalCross-Sectional StudiesInfectious DiseasesSputumFemaleParasitologymedicine.symptombusinessTransactions of The Royal Society of Tropical Medicine and Hygiene
researchProduct

Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial …

2016

Summary Background Women with a history of venous thromboembolism (VTE) have a 2% to 10% absolute risk of VTE recurrence during subsequent pregnancies. Therefore, current guidelines recommend that all pregnant women with a history of VTE receive pharmacologic thromboprophylaxis. The optimal dose of low-molecular-weight heparin (LMWH) for thromboprophylaxis is unknown. In the Highlow study (NCT 01828697; www.highlowstudy.org ), we compare a fixed low dose of LMWH with an intermediate dose of LMWH for the prevention of pregnancy-associated recurrent VTE. We present the rationale and design features of this study. Methods The Highlow study is an investigator-initiated, multicentre, internation…

Adultmedicine.medical_specialtymedicine.drug_classPregnancy Complications CardiovascularLow molecular weight heparinHemorrhage030204 cardiovascular system & hematologylaw.inventionYoung Adult03 medical and health sciencesClinical trials0302 clinical medicineRandomized controlled trialRecurrencePregnancylawInternal medicineVenous thrombosisSecondary PreventionHumansMedicinecardiovascular diseasesPregnancy030219 obstetrics & reproductive medicineProphylaxisbusiness.industryPostpartum PeriodAbsolute risk reductionAnticoagulantsVenous ThromboembolismHematologyHeparinHeparin Low-Molecular-Weightmedicine.diseaseequipment and suppliesLMWHSurgeryClinical trialVenous thrombosisTreatment OutcomeGestationFemalebusinessmedicine.drug
researchProduct